![]() | Novartis Institutes for Biomedical Research Invests in Parvus Therapeutics |
2016
Areas | Corporate Finance and Securities, Health Care Law, Technology |
Summary
Goodmans represented Novartis Institutes for BioMedical Research Inc. with respect to its investment in Parvus Therapeutics Inc.